You searched for: dicot

Dicot reports phase IIa results for LIB-01 – the stock plummets

On Thursday, the drug development company Dicot Pharma presented results from its clinical proof-of-concept phase IIa study with the candidate LIB-01 for the treatment of...

Dicot Pharma reports positive Phase IIa results

Springtime for biotech – the thaw has begun

It has sometimes felt discouraging to walk through the biotech sector's wolf winter. A barren capital raising landscape has offered strong headwinds that...

Integrum’s fiasco: a stain on a good record

What a soup we've been served this week. It looked like it would be a nice exit for Integrum's founder...

Dicot Pharma included in global stock index

Dicot Pharma completes phase IIa study

Dicot Pharma completes recruitment for phase IIa study

Oxcia enters into dermatology collaboration agreement with LEO Pharma

Oxcia is taking a strategic step to broaden the scope of its drug candidate OXC-101 by entering into a research collaboration with the...

The most shorted life science stocks in the Nordics

US interest rate cuts are finally here and are expected to ease the pressure on a hard-hit life sciences sector. However, it is...

Dicot's phase I study completes recruitment

Dicot continues to stay on schedule in its Phase I clinical study. In January, the company, which is developing the next generation of potency drugs,...

Dicot's CEO: "Several prominent people want to join the journey"

Uppsala-based Dicot recently released its report for the past year. CEO Elin Trampe notes that there is a large...

Dicots LIB-01 exhibits good safety profile

Uppsala-based Dicot is currently conducting a Phase I study with the potency drug candidate LIB-01 to investigate the safety profile in humans. The company completed...